Lombard Medical Technologies Shelfs U.S. IPO Plans Indefinitely

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Lombard Medical indefinitely postpones its U.S. initial public offering, citing adverse market conditions. Lombard Medical tables U.S. IPO

Lombard Medical Technologies (LON:LMT) said today that it’s tabling a planned initial public offering on the NASDAQ exchange due to adverse conditions in the U.S. stock market.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC